<p>Photos taken at 1, 2, and 4 weeks after the induction of corneal NV in no treatment group and 1, 2, and 4 weeks after bevacizumab injection in early and late treatment groups. Staining of CD 31 surrounded by HMW-MAA was found at week 2 and 4 in no treatment group, and week 1, 2, 4 after bevacizumab injection in late treatment group, which demonstrated the presence of pericytes around the vascular endothelial cells. Scale bar: 40 μm. Red: CD31; Green:HMW-MAA; Blue: Hoechst33258 which stains nucleus.</p
<p>Immunostaining of endothelial cells with an anti-rabbit CD31 antibody on tissues of normal AT (co...
PURPOSE: To evaluate the effect of subconjunctival bevacizumab (Avastin) administration on corneal n...
PURPOSE: To evaluate the use of subconjunctival bevacizumab on corneal neovascularization in an expe...
<p>Photos taken at 1, 2, and 4 weeks after the induction of corneal NV in no treatment group and 1, ...
<p>(A) On normal cornea, VEGF, VEGFR1 and VEGFR2 were found to be presented on corneal epithelium. (...
<p>No significant difference in the CD11b+ cells in tissue sections of rabbit corneas transfected wi...
<p>Panel on left side shows immunoblot and on right side shows quantification of western blotting da...
<p>Lectin (A–F) and collagen type IV (G–L) immunostaining was carried out in corneal tissue sections...
<p>A) sham group; B) rabbit AD-MSCs. Note the intense edema causing thickening of the corneal stroma...
PURPOSE. Bevacizumab is a potent recombinant humanized monoclonal antibody directed against vascular...
<p>(A) Representative images of immunofluorescence staining with primary anti-CD31 and anti-NG2 anti...
<p>A) sham group; B) human AD-MSCs; C) activated human AD-MSCs; and D) rabbit AD-MSCs. Note the inte...
<p>Double immunofluorescent detection of BrdU (yellow) and CD31-positive blood vessels (red) in WT a...
Immunostainings with anti-CD68 for macrophages (), anti-TCR alpha/beta for lymphocytes (), anti-MCA9...
Introduction: Vasculogenic mimicry, as previously described in aggressive melanoma, is characterized...
<p>Immunostaining of endothelial cells with an anti-rabbit CD31 antibody on tissues of normal AT (co...
PURPOSE: To evaluate the effect of subconjunctival bevacizumab (Avastin) administration on corneal n...
PURPOSE: To evaluate the use of subconjunctival bevacizumab on corneal neovascularization in an expe...
<p>Photos taken at 1, 2, and 4 weeks after the induction of corneal NV in no treatment group and 1, ...
<p>(A) On normal cornea, VEGF, VEGFR1 and VEGFR2 were found to be presented on corneal epithelium. (...
<p>No significant difference in the CD11b+ cells in tissue sections of rabbit corneas transfected wi...
<p>Panel on left side shows immunoblot and on right side shows quantification of western blotting da...
<p>Lectin (A–F) and collagen type IV (G–L) immunostaining was carried out in corneal tissue sections...
<p>A) sham group; B) rabbit AD-MSCs. Note the intense edema causing thickening of the corneal stroma...
PURPOSE. Bevacizumab is a potent recombinant humanized monoclonal antibody directed against vascular...
<p>(A) Representative images of immunofluorescence staining with primary anti-CD31 and anti-NG2 anti...
<p>A) sham group; B) human AD-MSCs; C) activated human AD-MSCs; and D) rabbit AD-MSCs. Note the inte...
<p>Double immunofluorescent detection of BrdU (yellow) and CD31-positive blood vessels (red) in WT a...
Immunostainings with anti-CD68 for macrophages (), anti-TCR alpha/beta for lymphocytes (), anti-MCA9...
Introduction: Vasculogenic mimicry, as previously described in aggressive melanoma, is characterized...
<p>Immunostaining of endothelial cells with an anti-rabbit CD31 antibody on tissues of normal AT (co...
PURPOSE: To evaluate the effect of subconjunctival bevacizumab (Avastin) administration on corneal n...
PURPOSE: To evaluate the use of subconjunctival bevacizumab on corneal neovascularization in an expe...